Építés alatt – nem éles oldal
Belépés
Még nem keres résztvevőt itt: Egyesült ÁllamokFázis nélkül

Efficacy and Feasibility Trial of a Portable Near Infra-Red Hematoma Imager (NIRD-HI)

A legfontosabb adatok

Ki végzi
The Geneva Foundation
Hol
San Antonio (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Toborzás még nem indult
Résztvevők
80 fő, tervezett
Kezdés
2026. jan. 1.
Várható befejezés
2027. szept. 29.
A vizsgálat típusa
Megfigyeléses, 2 csoport
A vizsgált kezelések
  • NIRD-HI scan at the time of enrollment
  • Secondary NIRD-HI scan when a planned repeat CT is performed
A regiszteradat frissítve
2026. január 13.

Ki vehet részt

Életkor
18 év – 89 év
Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 12 feltétel megnézéseKevesebb

Ki vehet részt

  • 18 to 89 years of age
  • Able to provide written informed consent either by self or legally authorized representative
  • Received head CT imaging on admission
  • Able to complete at least one NIRD-HI scan within 4 hours of head CT
  • Non-operative management planned

Ki nem vehet részt

  • Any condition or finding that makes the patient unsuitable for image acquisition in the Investigator's opinion
  • Presence of penetrating or non-survivable injuries
  • Hemorrhagic shock or large volume transfusion [>3 units of any blood product within; 1 hour of scan]
  • Large open skull wounds, scalp lacerations or surface hematomas prohibiting safe or comfortable sensor placement
  • Presence of heat tattoos or intracranial metal fixtures
  • Cervical injury prolonging C-spine collar
  • Known prisoners or wards of state

A fő feltételek kérdésként

Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.

  • 18 és 89 év között vagy?

Helyszínek itt: Egyesült Államok

  • Brooke Army Medical CenterSan Antonio, Egyesült ÁllamokContact: Marisol Resendiz, PhDToborzás még nem indult

A vizsgálatról

Mit akar kideríteni a vizsgálat

Traumatic Brain Injury (TBI) is a leading cause of death and disability among military personnel, Veterans, and civilians. One of the most dangerous complications of moderate-to-severe TBI is intracranial hemorrhage (ICH). If not identified and treated promptly, ICH can rapidly lead to worsening neurological damage or death. Current diagnostic tools, such as CT scans, are highly effective but impractical for battlefield or resource-limited environments due to their large size and infrastructure dependency.

A teljes eredeti leírásKevesebb

The Near-Infrared Detection-Head Imaging (NIRD-HI) system is an innovative, noninvasive device using Near-Infrared Spectroscopy (NIRS) to identify abnormal blood accumulation. Unlike traditional tools, NIRD-HI is compact, lightweight, and portable, making it suitable for remote or austere settings. By dynamically imaging the brain, it generates 3D visualizations that pinpoint the size and location of bleeds, including complex bilateral injuries. This offers a significant improvement over current point-of-injury technologies that lack the resolution to reliably diagnose all forms of ICH.

This study supports the FY24 Combat Readiness Medical Research Program by advancing battlefield diagnostic and triage capabilities. The research will:

* Evaluate NIRD-HI's accuracy compared to CT imaging. * Assess feasibility in real-world acute care settings. * Investigate its ability to monitor changes in ICH over time.

These objectives address the military's need for tools that improve rapid diagnosis and decision-making during emergencies. Implementing this research can revolutionize TBI management. For Service Members, NIRD-HI promises a field-ready solution for early detection, enabling faster intervention and more effective triage. By reducing diagnostic delays, it could save lives and prevent long-term complications. Furthermore, the system supports prolonged field care by providing continuous monitoring of evolving injuries.

The benefits extend to civilian healthcare, particularly in rural or underserved areas lacking advanced imaging. This accessibility can improve trauma care outcomes for millions, reduce the burden on healthcare systems, and provide equitable distribution of life-saving technology. By addressing gaps in battlefield medicine, this project aims to enhance medical readiness and improve survivability in the most challenging environments.

A vizsgálat 2 csoportja

  • 40 participants with positive head bleed on CT report

    Subjects with positive head CT reports that may have a diagnosis of TBI or intracranial hemorrhage

    Kezelés: NIRD-HI scan at the time of enrollment és Secondary NIRD-HI scan when a planned repeat CT is performed

  • 40 participants with negative head bleed on CT report

    Subjects without positive head CT reports that may have a diagnosis of TBI or intracranial hemorrhage

    Kezelés: NIRD-HI scan at the time of enrollment és Secondary NIRD-HI scan when a planned repeat CT is performed

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
An Efficacy and Feasibility Trial of a Portable Near Infra-Red Hematoma Imager for Detection of Intracranial Hemorrhage in the Acute Care Setting
Kérdések a feltételekről
Forrás: NCT07338383: ki vehet részt
A regiszteradat frissítve
2026. január 13.